| PERIOD ENDING | 1-May-09 | 30-Jan-09 | 31-Oct-08 | 1-Aug-08 | | Total Revenue | 11,832,000 | 9,984,000 | 11,727,000 | 14,510,000 | | Cost of Revenue | 7,636,000 | 6,616,000 | 7,742,000 | 9,528,000 | | | Gross Profit | 4,196,000 | 3,368,000 | 3,985,000 | 4,982,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,944,000 | 2,610,000 | 2,726,000 | 3,013,000 | | Non Recurring | 13,000 | 32,000 | 32,000 | 20,000 | | Others | 401,000 | 397,000 | 385,000 | 382,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 838,000 | 329,000 | 842,000 | 1,567,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,000 | 18,000 | (9,000) | 5,000 | | Earnings Before Interest And Taxes | 843,000 | 347,000 | 833,000 | 1,572,000 | | Interest Expense | 83,000 | 88,000 | 56,000 | 74,000 | | Income Before Tax | 760,000 | 259,000 | 777,000 | 1,498,000 | | Income Tax Expense | 284,000 | 97,000 | 289,000 | 560,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 476,000 | 162,000 | 488,000 | 938,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 476,000 | 162,000 | 488,000 | 938,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $476,000 | $162,000 | $488,000 | $938,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
